Corrado Tamburino

Professor of Cardiology

MD PhD

Ferrarotto Hospital, Policlinico Hospital and University of Catania, Catania, Italy

  • Radcliffe

Biography

Full Professor of Cardiology and Director of the Clinical Cardiology Division of the Ferrarotto Hospital and the Policlinico Gaspare Rodolico Hospital,

Director of the Cardiology Specialization School and Head of Cardio-Thoraco-Vascular Department and Organ Transplant ,Azienda Policlinico-Vittorio Emanuele, University of Catania

Dr Tamburino is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

Read more

Media

Antonio Colombo, Corrado Tamburino, James Spratt, et al

TCT Connect 2020: The SCOPE II Trial

Corrado Tamburino,

ESC 2015: Clinical use of IVUS *Teaser Trailer*

Justin E Davies, Corrado Tamburino,

ESC 2015: The use of IVUS in Clinical Practice: Complex Lesions and BVS Implantation

Justin E Davies, Corrado Tamburino,

ESC 2015: IVUS in Complex Lesions

Justin E Davies, Corrado Tamburino,

ESC 2015: IVUS for BVS Implants

Justin E Davies, Corrado Tamburino,

ESC 2015: IVUS Clinical Case

Justin E Davies, Corrado Tamburino,

Simon Kennon, Jonathan Byrne, Enrico Ferrari, et al

image

Simon Kennon, Carlos E Ruiz, Lars Søndergaard, et al

TAVI

Simon Kennon, Jonathan Byrne, Enrico Ferrari, et al

TAVI

Simon Kennon, Corrado Tamburino, Jonathan Byrne, et al

TAVI Round Table Discussion - Session 2

Jonathan Byrne, Simon Kennon, Enrico Ferrari, et al

Articles by Corrado Tamburino, Professor of Cardiology

Long-term Transcatheter Aortic Valve Durability

Giuliano Costa, Enrico Criscione, Denise Todaro, et al

Published:

Citation: Interventional Cardiology Review 2019;14(2):62–9.

DOI:

https://doi.org/10.15420/icr.2019.4.2
Assessing Patients for Left Main Percutaneous Coronary Intervention - Considerations and Practicalities of Risk Scores

Anna Caggegi, Davide Capodanno, Claudia Tamburino, et al

Citation: Interventional Cardiology 2012;7(1):24–7

DOI:

https://doi.org/10.15420/icr.2012.7.1.24
Percutaneous Heart Valve Therapy - Options, Risks and Benefits

Gian Paolo Ussia, Marco Barbanti, Valeria Cammalleri, et al

Citation: European Cardiology 2010;6(1):65–74

DOI:

https://doi.org/10.15420/ecr.2010.6.1.65
The Sicilian Drug-eluting Stent Registry - Risk-Benefit and Cost-effectiveness Analyses of Drug-eluting Stents versus Bare-metal Stents

Corrado Tamburino, Davide Capodanno,

Citation: Interventional Cardiology 2008;3(1):59-61

DOI:

https://doi.org/10.15420/icr.2008.3.1.59